Volume: k. The Arena Pharmaceuticals stock price gained 0. During the day the stock fluctuated 2. The price has risen in 6 of the last 10 days and is up by 8. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 52 thousand more shares were traded than the day before. The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled.
Given the current short-term trend, the stock is expected to rise Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Arena Pharmaceuticals stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, October 14, , and so far it has fallen Further fall is indicated until a new bottom pivot has been found.
No Saved Watchlists Create a list of the investments you want to track. Create Watchlist …or learn more. Uh oh Something went wrong while loading Watchlist. Go to Watchlist. No Recent Tickers Visit a quote page and your recently viewed tickers will be displayed here.
Search Tickers. MarketWatch Dow Jones. ET by Michael Ashbaugh. Premium Charting a bullish divergence, Nasdaq extends within view of 10, mark Jun. Arena Pharmaceuticals upgraded to overweight from neutral at J. Morgan Jan. ET by Tomi Kilgore. ET by Chris Matthews. Arena Pharmaceutical shares slide after drug maker reports disappointing financial results May. ET by Sue Chang.
The company has one internally discovered drug, lorcaserin, which has been approved and is marketed in the U. It is commercialized under the brand name Belviq. The company is collaborating with Eisai to market Belviq in other countries.
The company's pipeline contains drugs targeting autoimmune diseases, vascular diseases, thrombotic diseases, dementia-associated psychosis, nervous system issues, and pain.
Share this article:. Like the earnings yield, which shows the anticipated yield or return on a stock based on the earnings and the price paid, the cash yield does the same, but with cash being the numerator instead of earnings. Many investors prefer EV to just Market Cap as a better way to determine the value of a company. That means these items are added back into the net income to produce this earnings number. Since there is a fair amount of discretion in what's included and not included in the 'ITDA' portion of this calculation, it is considered a non-GAAP metric.
Conventional wisdom says that a PEG ratio of 1 or less is considered good at par or undervalued to its growth rate.
A value greater than 1, in general, is not as good overvalued to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth. Book value is defined as total assets minus liabilities, preferred stocks, and intangible assets. In short, this is how much a company is worth. Investors use this metric to determine how a company's stock price stacks up to its intrinsic value.
Note; companies will typically sell for more than their book value in much the same way that a company will sell at a multiple of its earnings. So, as with other valuation metrics, it's a good idea to compare it to its relevant industry.
It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. A value under 20 is generally considered good. Our testing substantiates this with the optimum range for price performance between It is the most commonly used metric for determining a company's value relative to its earnings.
In this example, we are using the consensus earnings estimate for the Current Fiscal Year F1. In general, a lower number or multiple is usually considered better that a higher one. In general, the lower the ratio is the better.
It's calculated as earnings divided by price. A yield of 8. The most common way this ratio is used is to compare it to other stocks and to compare it to the 10 Year T-Bill. Conversely, if the yield on stocks is higher than the 10 Yr. Since bonds and stocks compete for investors' dollars, a higher yield typically needs to be paid to the stock investor for the extra risk being assumed vs. It is used to help gauge a company's financial health.
A higher number means the company has more debt to equity, whereas a lower number means it has less debt to equity. When comparing this ratio to different stocks in different industries, take note that some businesses are more capital intensive than others. So it's a good idea to compare a stock's debt to equity ratio to its industry to see how it stacks up to its peers first. Cash flow can be found on the cash flow statement. It's then divided by the number of shares outstanding to determine how much cash is generated per share.
It's used by investors as a measure of financial health. Cash is vital to a company in order to finance operations, invest in the business, pay expenses, etc.
Since cash can't be manipulated like earnings can, it's a preferred metric for analysts. Using this item along with the 'Current Cash Flow Growth Rate' in the Growth category above , and the 'Price to Cash Flow ratio' several items above in this same Value category , will give you a well-rounded indication of the amount of cash they are generating, the rate of their cash flow growth, and the stock price relative to its cash flow.
This longer-term historical perspective lets the user see how a company has grown over time. Note: there are many factors that can influence the longer-term number, not the least of which is the overall state of the economy recession will reduce this number for example, while a recovery will inflate it , which can skew comparisons when looking out over shorter time frames. The longer-term perspective helps smooth out short-term events. Projected EPS Growth looks at the estimated growth rate for one year.
It takes the consensus estimate for the current fiscal year F1 divided by the EPS for the last completed fiscal year F0 actual if reported, the consensus if not. That does not mean that all companies with large growth rates will have a favorable Growth Score. Many other growth items are considered as well.
But, typically, an aggressive growth trader will be interested in the higher growth rates. Cash Flow is net income plus depreciation and other non-cash charges.
A strong cash flow is important for covering interest payments, particularly for highly leveraged companies. Cash Flow is a measurement of a company's health. It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at. A positive change in the cash flow is desired and shows that more 'cash' is coming in than 'cash' going out.
The Historical Cash Flow Growth is the longer-term year annualized growth rate of the cash flow change. Once again, cash flow is net income plus depreciation and other non-cash charges.
0コメント